Geeglobia India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 1.00 M
as on 03-01-2025
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
as on 03-01-2025
- Revenue 182055.17%
(FY 2022)
- Profit -123.75%
(FY 2022)
- Ebitda -3217.24%
(FY 2022)
- Net Worth -0.01%
(FY 2022)
- Total Assets -6.26%
(FY 2022)
About Geeglobia India
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.25 Cr.
Sukhjinder Ghotra and Simarjit Ghotra serve as directors at the Company.
- CIN/LLPIN
U74900PN2013PTC146128
- Company No.
146128
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2013
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Geeglobia India Private Limited offer?
Geeglobia India Private Limited offers a wide range of products and services, including Adventure & Trekking Tours, Adventure Tours, Tour Operators and Travel Agents, Tour Packages, Honeymoon Packages, Luxury Train Tours, Travel Service, Backwaters Tour Package, Hill Station Packages, International Tour Packages.
Who are the key members and board of directors at Geeglobia India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhjinder Ghotra  | Director | 31-Jan-2013 | Current |
| Simarjit Ghotra | Director | 31-Jan-2013 | Current |
Financial Performance of Geeglobia India.
Geeglobia India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 182055.17% increase. The company also saw a substantial fall in profitability, with a 123.75% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geeglobia India?
In 2019, Geeglobia India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 25 Jun 2015 | ₹7.50 M | Open |
Punjab & Sind Bank Creation Date: 23 Dec 2013 | ₹5.00 M | Open |
How Many Employees Work at Geeglobia India?
Unlock and access historical data on people associated with Geeglobia India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geeglobia India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geeglobia India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
